Michelle Birdsell
Psychiatry · Overland Park, KSNPI 1386838605
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.4% of the total across 311 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.
Across 311 payments — averaging $12.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$547
- AbbVie$541
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$296
- Otsuka America Pharmaceutical, Inc.$291
- Bausch Health US, LLC$279
- Johnson & Johnson$265
- plus $2K from 20 others
What the payments were for
- Food & beverage$3,89697%
- Education$1033%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 38 | $547 |
| AbbVie(2 entities) | 73 | $541 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $296 |
| Otsuka America Pharmaceutical, Inc. | 17 | $291 |
| Bausch Health US, LLC | 21 | $279 |
| Johnson & Johnson | 15 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $246 |
| Lundbeck LLC | 10 | $185 |
| Supernus Pharmaceuticals, Inc. | 18 | $163 |
| Teva Pharmaceuticals USA, Inc. | 8 | $154 |
| Ironshore Pharmaceuticals Inc. | 9 | $153 |
| Corium, LLC | 22 | $139 |
| Neos Therapeutics, LP | 8 | $131 |
| Neurocrine Biosciences, Inc. | 6 | $118 |
| Axsome Therapeutics, Inc. | 6 | $112 |
| Alkermes, Inc. | 5 | $99 |
| Merck | 5 | $81 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| Eisai Inc. | 2 | $37 |
| Shire North American Group Inc | 2 | $26 |
| Adlon Therapeutics L.p. | 1 | $20 |
| Noven Therapeutics, LLC | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,999 in reported general payments places this provider in the 80th percentile of 259 psychiatry providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 13 | $111,167 |
| VraylarCariprazine Hcl | 27 | $38,683 |
| AdderallDextroamphetamine/Amphetamine | 11 | $10,677 |
| VyvanseLisdexamfetamine Dimesylate | 14 | $7,476 |
| Duloxetine Hcl | 91 | $2,648 |
| Clorazepate Dipotassium | 19 | $2,363 |
| Oxcarbazepine | 19 | $2,144 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 60 | $1,977 |
| Bupropion XlBupropion Hcl | 64 | $1,894 |
| Gabapentin | 72 | $1,873 |
| Quetiapine Fumarate | 76 | $1,406 |
| Carbamazepine | 21 | $1,242 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 14 | $1,167 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 54 | $1,062 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $930 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $118 | $111,16713 claims |
| AbbVieVraylar | $541 | $38,68327 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Adderall, Vyvanse | $246 | $18,15325 claims |
| Almatica Pharma LLCSertraline Hcl | $14 | $44056 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 259 psychiatry providers in Kansas.
Other psychiatry in Overland Park
- Sasha HamdaniOverland Park$104K
- Irfan HandooOverland Park$21K
- Brent MenningerOverland Park$7K
- Richard WarnerOverland Park$7K
- Anne ClarkOverland Park$7K
- David WichmanManhattan$613K
- Kevin MaysLeawood$548K
- Sheldon PreskornWichita$498K
- James OwensSalina$433K
- Christine GlennKansas City$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.